241 results on '"Mitrofanova, Antonina"'
Search Results
2. Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC
Catalog
Books, media, physical & digital resources
3. High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments
4. Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
5. Random survival forest model identifies novel biomarkers of event-free survival in high-risk pediatric acute lymphoblastic leukemia
6. Genome-wide analysis of therapeutic response uncovers molecular pathways governing tamoxifen resistance in ER+ breast cancer
7. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
8. A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
9. The expression of YWHAZ and NDRG1 predicts aggressive outcome in human prostate cancer
10. Calling Variants in the Clinic: Informed Variant Calling Decisions Based on Biological, Clinical, and Laboratory Variables
11. Big Data and Its Emerging Role in Precision Medicine and Therapeutic Response
12. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
13. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
14. Tissue-specific biological aging predicts progression in prostate cancer and acute myeloid leukemia
15. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition
16. Identification of an NKX3.1-G9a-UTY transcriptional regulatory network that controls prostate differentiation
17. pathCHEMO, a generalizable computational framework uncovers molecular pathways of chemoresistance in lung adenocarcinoma
18. Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
19. Table S4 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
20. Index of Supplementary Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
21. Detailed Materials and Methods from OncoLoop: A Network-Based Precision Cancer Medicine Framework
22. Supplementary Figures S1-S11 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
23. Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
24. Data from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
25. Supplementary Tables from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
26. Data from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
27. Dataset 1 from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
28. Supplementary Datasets from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
29. Supplementary Materials and Methods from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
30. Supplementary Data Index from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
31. Supplementary Figures from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
32. Supplementary Figures 1 through 7, Supplementary Tables 1 through 7, and Supplementary Materials and Methods from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
33. Data from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
34. Supplementary Table 8 from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
35. Supplementary Table 7 from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
36. Supplementary Table 6A from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
37. Supplementary Table 6 from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
38. Data from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
39. Supplementary Table 5 from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
40. Supplementary Table 4 from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
41. Supplementary Figure 5B from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
42. Supplementary Table 4 from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
43. Supplementary Figures 1-3, Tables 1-3, Table 7, Legends for Figures 1-3, Tables 1-7 from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
44. Supplementary Table 5A from B-Raf Activation Cooperates with PTEN Loss to Drive c-Myc Expression in Advanced Prostate Cancer
45. Supplementary Figure 1 and Tables 1 - 3 from Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
46. Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models
47. OncoLoop: A Network-Based Precision Cancer Medicine Framework
48. Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
49. NSD2 is a conserved driver of metastatic prostate cancer progression
50. Syntax-Driven Private Evaluation of Quantified Membership Queries
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.